Thus, SPRY2 has a significantly suppressive effect on inflammatory responses in RA, and the enhancement of SPRY2 activity in FLSs contributes to the amelioration or prevention-orientated treatment of RA. This evidence concerns the gene SPRY2 and rheumatoid arthritis.